The sublingual route may produce different central nervous system effects compared to intranasal delivery because of the different absorption pathway, a distinction relevant to those studying brain repair peptides
Determine whether benefits persist during the off period or require continuous use to maintain
A high-affinity, saturable transport mechanism for DSIP at the blood-brain barrier was demonstrated in vascularly perfused guinea pig brain, with the highest unidirectional transfer rate in the hippocampus (Kin 1.66 L/min/g) [9]
Given its sleep-inducing and neuroprotective effects, DSIP has been proposed as a potential therapeutic agent for a variety of conditions, including sleep disorders, chronic pain, and neurodegenerative diseases
An amidated C-terminal tyrosine is not tolerated for high affinity peptide interactions with the CTR in the absence of RAMPs
The standard retatrutide dose schedule is: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Week 17 onward: 8-12 mg once weekly (maintenance) In the combination context, many researchers find that 8 mg is sufficient for their maintenance dose rather than pushing to 12 mg, because the cagrilintide provides enough additional appetite suppression and satiety to make the extra 4 mg of retatrutide unnecessary
